Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension

Clinical trial NCT03554291 · COMPLETED

Trial details

NCT number: NCT03554291
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Right Heart Failure

Start date: 2019-05-01
Primary completion: 2023-07-11
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.